Literature DB >> 32419977

PET/CT in pediatric oncology.

Gabriele Masselli1,2, Cristina De Angelis1, Saadi Sollaku1,2, Emanuele Casciani2, Gianfranco Gualdi2.   

Abstract

The use of PET/CT in adult oncology has been consolidated by several and authoritative multicentric studies, metanalyses and systematic reviews. International guidelines help everyday nuclear medicine specialists, oncologists and radiologists in choosing the most suitable diagnostic path for each patient. Classifications based on traditional imaging and PET/CT findings define the most appropriate treatment and can predict the outcome for different types of malignancies. However, compared to adult patients the use of PET/CT in pediatric oncology is often burdened by lack of systematic and large multicentric studies and consequently accurate and precise guidelines. The cause of this shortage of large trials may be attributed to the rarity of these neoplasms and to the fear of long-term radiation effects on this peculiar category of patients. The aim of this article is to review the applications of PET/CT for imaging the most common pediatric neoplasms. AJNMMI
Copyright © 2020.

Entities:  

Keywords:  PET/CT; oncology; pediatric

Year:  2020        PMID: 32419977      PMCID: PMC7218696     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  66 in total

Review 1.  MR imaging of neoplastic central nervous system lesions: review and recommendations for current practice.

Authors:  M Essig; N Anzalone; S E Combs; À Dörfler; S-K Lee; P Picozzi; A Rovira; M Weller; M Law
Journal:  AJNR Am J Neuroradiol       Date:  2011-10-20       Impact factor: 3.825

2.  Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial.

Authors:  Christian Furth; Ingo G Steffen; Holger Amthauer; Juri Ruf; Daniel Misch; Stefan Schönberger; Carsten Kobe; Timm Denecke; Brigitte Stöver; Hubertus Hautzel; Günter Henze; Patrick Hundsdoerfer
Journal:  J Clin Oncol       Date:  2009-08-10       Impact factor: 44.544

Review 3.  Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

Authors:  Nathalie L Albert; Michael Weller; Bogdana Suchorska; Norbert Galldiks; Riccardo Soffietti; Michelle M Kim; Christian la Fougère; Whitney Pope; Ian Law; Javier Arbizu; Marc C Chamberlain; Michael Vogelbaum; Ben M Ellingson; Joerg C Tonn
Journal:  Neuro Oncol       Date:  2016-04-21       Impact factor: 12.300

4.  Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

Authors:  T A Lister; D Crowther; S B Sutcliffe; E Glatstein; G P Canellos; R C Young; S A Rosenberg; C A Coltman; M Tubiana
Journal:  J Clin Oncol       Date:  1989-11       Impact factor: 44.544

Review 5.  Clinical update regarding general anesthesia-associated neurotoxicity in infants and children.

Authors:  M Ruth Graham
Journal:  Curr Opin Anaesthesiol       Date:  2017-12       Impact factor: 2.706

Review 6.  (18)F-Fluorodeoxyglucose PET and PET/CT in Pediatric Musculoskeletal Malignancies.

Authors:  Frederick D Grant; Laura A Drubach; S Ted Treves
Journal:  PET Clin       Date:  2010-06-17

7.  The usefulness of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the clinical evaluation of brain tumors in children and adolescents.

Authors:  Veronika Dunkl; Corvin Cleff; Gabriele Stoffels; Natalie Judov; Sevgi Sarikaya-Seiwert; Ian Law; Lars Bøgeskov; Karsten Nysom; Sofie B Andersen; Hans-Jakob Steiger; Gereon R Fink; Guido Reifenberger; Nadim J Shah; Heinz H Coenen; Karl-Josef Langen; Norbert Galldiks
Journal:  J Nucl Med       Date:  2014-12-18       Impact factor: 10.057

8.  Expression of somatostatin receptors in childhood neuroblastoma.

Authors:  C L Moertel; J C Reubi; B S Scheithauer; D J Schaid; L K Kvols
Journal:  Am J Clin Pathol       Date:  1994-12       Impact factor: 2.493

9.  Combined positron emission tomography-computed tomography: the historical perspective.

Authors:  David W Townsend
Journal:  Semin Ultrasound CT MR       Date:  2008-08       Impact factor: 1.875

10.  Measured human dosimetry of 68Ga-DOTATATE.

Authors:  Ronald C Walker; Gary T Smith; Eric Liu; Brandon Moore; Jeff Clanton; Michael Stabin
Journal:  J Nucl Med       Date:  2013-03-20       Impact factor: 10.057

View more
  4 in total

1.  Dynamic PET imaging with ultra-low-activity of 18F-FDG: unleashing the potential of total-body PET.

Authors:  Xiaoli Lan; Kevin Fan; Ke Li; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-30       Impact factor: 9.236

Review 2.  Clinical application of 18F-DOPA PET/TC in pediatric patients.

Authors:  Gabriele Masselli; Emanuele Casciani; Cristina De Angelis; Saadi Sollaku; Gianfranco Gualdi
Journal:  Am J Nucl Med Mol Imaging       Date:  2021-04-15

3.  18F-FDG PET/CT for Response Assessment in Pediatric Sebaceous Carcinoma of the Parotid Gland.

Authors:  Adrien Holzgreve; Thomas Pfluger; Irene Schmid; Orlando Guntinas-Lichius; Wolfgang G Kunz; Jens Ricke; Peter Bartenstein; Nathalie L Albert; Marcus Unterrainer
Journal:  Diagnostics (Basel)       Date:  2020-11-06

4.  A dedicated paediatric [18F]FDG PET/CT dosage regimen.

Authors:  Christina P W Cox; Daniëlle M E van Assema; Frederik A Verburg; Tessa Brabander; Mark Konijnenberg; Marcel Segbers
Journal:  EJNMMI Res       Date:  2021-07-19       Impact factor: 3.138

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.